HOWL
WerewolfยทNASDAQ
--
--(--)
--
--(--)
HOWL Profile
Werewolf Therapeutics, Inc.
An innovative biopharmaceutical company that develops engineered therapeutics to stimulate the body's immne system for the treatment of cancer
200 Talcott Ave, 2nd Floor, Watertown, Massachusetts 02472
--
Werewolf Therapeutics, Inc., was incorporated under the laws of the State of Delaware on October 19, 2017. The company is an innovative biopharmaceutical company that develops therapies designed to stimulate the body's immune system to treat cancer. The company is utilizing the company's proprietary PREDATOR platform to design conditionally activated molecules that stimulate adaptive immunity and innate immunity to address the limitations of traditional pro-inflammatory immunotherapies.
